Patient Involvement in Care, Psychosocial Outcomes, and Quality of Life in Hypertrophic Cardiomyopathy: A Pilot Study
- PMID: 38559336
- PMCID: PMC10980899
- DOI: 10.1016/j.cjco.2023.11.002
Patient Involvement in Care, Psychosocial Outcomes, and Quality of Life in Hypertrophic Cardiomyopathy: A Pilot Study
Abstract
This cross-sectional study evaluated the impact of patient involvement in care (PIC) on psychosocial outcomes and health-related quality of life (HRQoL) in patients with hypertrophic cardiomyopathy (HCM) (n = 34). Patients with low-to-moderate PIC were older than those with high PIC (66.8 years vs 57.3 years; P = 0.04). PIC was negatively correlated with depressive symptoms (r = -0.39; P = 0.02) and positively correlated with heart-focused attention (r = 0.39; P = 0.02). No significant correlations were observed between PIC and HRQoL. Greater PIC was associated with reduced depressive symptoms but increased cardiac anxiety. Future studies should investigate the relationship between PIC and HRQoL in a larger cohort.
Cette étude transversale visait à évaluer l’effet de la participation du patient à ses soins sur les issues psychosociales et la qualité de vie liée à la santé chez les patients atteints de cardiomyopathie hypertrophique (CMH) (n = 34). Les patients qui participaient peu ou modérément à leurs soins étaient plus âgés que ceux qui y participaient activement (66,8 ans vs 57,3 ans; p = 0,04). Il y a une corrélation négative entre la participation du patient aux soins et les symptômes dépressifs (r = -0,39; p = 0,02) et une corrélation positive entre la participation aux soins et l’attention portée au cœur (r = 0,39; p = 0,02). Aucune corrélation notable n’a été observée entre la participation du patient à ses soins et la qualité de vie liée à la santé. Une grande participation du patient à ses soins a été associée à une réduction des symptômes dépressifs, mais à une anxiété cardiaque accrue. D’autres études sont nécessaires pour examiner la relation entre la participation du patient à ses soins et la qualité de vie liée à la santé au sein d’une cohorte plus importante.
© 2023 The Authors.
Figures

Similar articles
-
Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire.Health Qual Life Outcomes. 2020 Oct 30;18(1):351. doi: 10.1186/s12955-020-01604-9. Health Qual Life Outcomes. 2020. PMID: 33126893 Free PMC article.
-
Psychosocial interventions for preventing and treating depression in dialysis patients.Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD004542. doi: 10.1002/14651858.CD004542.pub3. Cochrane Database Syst Rev. 2019. PMID: 31789430 Free PMC article.
-
Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.J Med Econ. 2023 Jan-Dec;26(1):1495-1506. doi: 10.1080/13696998.2023.2277076. Epub 2023 Nov 30. J Med Econ. 2023. PMID: 37902966
-
[Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1033-1038. doi: 10.3760/cma.j.issn.0253-3758.2017.12.006. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29325362 Chinese.
-
Right ventricular involvement in hypertrophic cardiomyopathy: evidence and implications from current literature.Scand Cardiovasc J. 2021 Aug;55(4):195-204. doi: 10.1080/14017431.2021.1901979. Epub 2021 Mar 24. Scand Cardiovasc J. 2021. PMID: 33759664
References
-
- Maron B.J., Maron M.S. Hypertrophic cardiomyopathy. Lancet. 2013;381:242–255. - PubMed
-
- Ingles J., Yeates L., Hunt L., et al. Health status of cardiac genetic disease patients and their at-risk relatives. Int J Cardiol. 2013;165:448–453. - PubMed
-
- Morgan J.F., O’Donoghue A.C., McKenna W.J., Schmidt M.M. Psychiatric disorders in hypertrophic cardiomyopathy. Gen Hosp Psychiatry. 2008;30:49–54. - PubMed
-
- Ingles J., Johnson R., Sarina T., et al. Social determinants of health in the setting of hypertrophic cardiomyopathy. Int J Cardiol. 2015;184:743–749. - PubMed
-
- Maron B.J., Nishimura R.A., Maron M.S. Shared decision-making in HCM. Nat Rev Cardiol. 2017;14:125–126. - PubMed
LinkOut - more resources
Full Text Sources